Funding for this research was provided by:
NIH Clinical Center
Received: 9 July 2018
Accepted: 25 November 2018
First Online: 10 December 2018
Ethics approval and consent to participate
: This study was approved by the NIH Addictions Institutional Review Board in March of 2018. All study participants will provide written informed consent.
: Not applicable.
: Drs. Ritterband and Thorndike have equity ownership in BeHealth Solutions, LLC, a company developing and making available products related to the research reported in this publication. Specifically, BeHealth Solutions, LLC has licensed the SHUTi program and the software platform on which it was built from the University of Virginia. The terms of this arrangement have been reviewed and approved by the University of Virginia and the National Institutes of Health in accordance with their conflict of interest policies.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.